Cleared Traditional

K141100 - OPTILITE C1 INACTIVATOR KIT

K141100 is the FDA 510(k) clearance for OPTILITE C1 INACTIVATOR KIT by The Binding Site Group , Ltd.. It is a Class 2 Immunology device (product code DBA) cleared through the Traditional 510(k) pathway after a 80-day FDA review.

K141100 · The Binding Site Group , Ltd. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2014
Decision
80d
Days
Class 2
Risk

K141100 is an FDA 510(k) clearance for the OPTILITE C1 INACTIVATOR KIT. Classified as Complement C1 Inhibitor (inactivator), Antigen, Antiserum, Control (product code DBA), Class II - Special Controls.

Submitted by The Binding Site Group , Ltd. (Birmingham, GB). The FDA issued a Cleared decision on July 18, 2014 after a review of 80 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5250 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all The Binding Site Group , Ltd. devices

Submission Details

510(k) Number K141100 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 29, 2014
Decision Date July 18, 2014
Days to Decision 80 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 104d · This submission: 80d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DBA Complement C1 Inhibitor (inactivator), Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DBA Complement C1 Inhibitor (inactivator), Antigen, Antiserum, Control

All 9
Devices cleared under the same product code (DBA) and FDA review panel - the closest regulatory comparables to K141100.
HUMAN C1 INACTIVATOR KIT FOR USE ON SPAPLUS
K122304 · The Binding Site Group , Ltd. · Apr 2013
DIMENSION VISTA C1 IN
K072965 · Dade Behring, Inc. · Dec 2007
K-ASSAY C1-INA
K011780 · Kamiya Biomedical Co. · Jul 2001
C1-INHIBITOR MICROTITER ASSAY DEVICE
K003747 · Baxter Healthcare Corp · Mar 2001
N ANTISERUM TO C1 INHIBITOR
K960257 · Behring Diagnostics, Inc. · Aug 1996
COMPLEMENT C1 INACTIVATOR KIT
K915431 · The Binding Site, Ltd. · Jan 1992